Fortis Advisors’s Organon & Co OGN Stock Holding History

Fortis Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,043	Closed	-$95.1K	–	199
2023 Q1	$95.1K	Buy	4,043 +3,912	+2,986%	+$105K	0.06%	124
2022 Q4	$3.66K	Hold	131	–	–	﹤0.01%	226
2022 Q3	$3K	Hold	131	–	–	﹤0.01%	223
2022 Q2	$4K	Hold	131	–	–	﹤0.01%	245
2022 Q1	$5K	Hold	131	–	–	﹤0.01%	254
2021 Q4	$4K	Sell	131 -300	-70%	-$9.77K	﹤0.01%	238
2021 Q3	$14K	Buy	431 +24	+6%	+$768	0.01%	213
2021 Q2	$12K	Buy	+407	New	+$13.4K	0.01%	221

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Fortis Advisors's OGN Position: Q2 2023 in Review

Fortis Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 4,043 shares — an estimated $95.1K sold.

Fortis Advisors first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $95.1K in Q1 2023. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Fortis Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Fortis Advisors sold 4,043 Organon & Co shares in Q2 2023, an estimated $95.1K.
Fortis Advisors first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
Fortis Advisors's Organon & Co position peaked at $95.1K in Q1 2023.
726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Fortis Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.